Switch to:
More From Other Websites
Is this the drug answer to Alzheimer's and Huntington's disease? Jun 24 2016
Five companies that could buy Ariad this year for as much as $2.9B Jun 23 2016
Timely use of Novartis' Entresto could prevent or postpone over 28,000 US deaths per year among... Jun 22 2016
CORRECTED (OFFICIAL)-Novartis aims to nearly triple biosimilar drugs on market by 2020 Jun 20 2016
Novartis aims to nearly triple biosimilar drugs on market by 2020 Jun 19 2016
Meet the Marijuana Industry Money-Man, Rob Hunt of Tuatara Capital Jun 18 2016
Roche skin cancer drugs "too expensive", says UK cost agency Jun 16 2016
Novartis expands partnership with Medicines for Malaria Venture to develop next-generation... Jun 15 2016
Pfizer, Merck, Other Big Pharmas Likely to Acquire Marijuana-Based Drug Companies Jun 13 2016
Colombia Makes Good On Its Threat Against Novartis AG (NVS) Jun 10 2016
Novartis Reports Positive Data on Biosimilar Candidates Jun 10 2016
An Inside Look at Incyte’s Product Portfolio Jun 10 2016
Novartis highlights long-term safety data of Revolade® in adults with chronic immune... Jun 10 2016
Novartis presents data showing Jakavi® is superior to best available therapy in patients with less... Jun 10 2016
Novartis (NVS) Announces Positive Results on Migraine Drug Jun 09 2016
Colombia to force Novartis to lower prices of cancer drug Jun 09 2016
Colombia to set new price for Novartis cancer drug -minister Jun 09 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK